The current findings showed that decremental loss of PTEN expression and activity in the host by in vivo injection of VO-OHpic significantly enhanced the growth of orthotopic breast cancer and its metastasis to distant organs, with the metastasis intensity in each organ being negatively related to the PTEN expression level in the organ. The gene discussed is PTEN; the disease is breast cancer.